Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROMIDEPSIN vs ROSIGLITAZONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROMIDEPSIN vs ROSIGLITAZONE: Safety Overview

Metric ROMIDEPSIN ROSIGLITAZONE
Total FAERS Reports 1,282 45,976
Deaths Reported 343 4,661
Death Rate 26.8% 10.1%
Hospitalizations 458 23,675
Average Patient Age 64.7 yrs 60.2 yrs
% Female Patients 46.5% 42.8%
FDA Approval Date Mar 13, 2020 Jan 25, 2013
Manufacturer Fresenius Kabi USA, LLC N/A
Marketing Status Prescription Discontinued